Sunshine BiopharmaSBFM 34 Days Inventory is 205.73 as of Mar. 2026, which is 1% above its 10-year median of 202.78. GuruFocus rates SBFM with a GF Score™ of 34/100 and a GF Value™ of $7.15 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, Sunshine Biopharma ranks worse than 64.49% on this metric.
The historical rank and industry rank for Sunshine Biopharma's Days Inventory or its related term are showing as below:
SBFM'
s Days Inventory Range Over the Past 10 Years
Min: 104.55 Med: 202.78 Max: 530.91
Current: 201.27
During the past 13 years, Sunshine Biopharma's highest Days Inventory was 530.91. The lowest was 104.55. And the median was 202.78.
SBFM's Days Inventory is ranked worse than 64.49% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs SBFM: 201.27
Sunshine Biopharma's Days Inventory
increased
from Mar. 2025 (171.05) to Mar. 2026 (205.73).
It might indicate that Sunshine Biopharma's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunshine Biopharma's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunshine Biopharma's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.65.
Sunshine Biopharma (NAS:SBFM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunshine Biopharma's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunshine Biopharma's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sunshine Biopharma Days Inventory Related Terms
Sunshine Biopharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Sunshine Biopharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SBFM vs PRFX, CTTH, CVSI: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Biopharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Biopharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sunshine Biopharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sunshine Biopharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Biopharma (SBFM) has a Days Inventory of 205.73 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunshine Biopharma and its competitors. This is near median its historical median of 202.78. Over the past decade, Sunshine Biopharma's Days Inventory has ranged from 104.55 to 530.91. According to the industry distribution chart, Sunshine Biopharma ranks #592 out of 918 companies in the Drug Manufacturers industry, placing it in the top 64.5%.
Is Sunshine Biopharma's Days Inventory too high?
Sunshine Biopharma's current Days Inventory of 205.73 is near median its 10-year median of 202.78. Over the past 10 years, this metric has ranged from a low of 104.55 to a high of 530.91. The Drug Manufacturers industry median Days Inventory is 164.43. Sunshine Biopharma's value of 205.73 is 25.1% above this industry median. Based on the distribution chart, Sunshine Biopharma ranks #592 out of 918 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sunshine Biopharma has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunshine Biopharma's Days Inventory compare to PRFX and CTTH?
According to the Drug Manufacturers industry distribution chart, Sunshine Biopharma ranks #592 out of 918 companies for Days Inventory. This places Sunshine Biopharma in the lower half of its industry. The industry median Days Inventory is 164.43. Sunshine Biopharma's value of 205.73 is 25.1% above this benchmark. Historically, Sunshine Biopharma's own Days Inventory has ranged from 104.55 to 530.91 over the past decade. While the company's 10-year median is 202.78 vs. the industry median of 164.43, Sunshine Biopharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Biopharma's current Days Inventory of 205.73 is 25.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunshine Biopharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Biopharma's current Days Inventory is 205.73, which is near median its own 10-year median of 202.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Biopharma (SBFM) is currently considered Possible Value Trap. The stock's GF Value™ is $7.15, compared to a current price of $2.14 — trading 70.1% below its estimated fair value. The current Days Inventory is 205.73, which is near median its 10-year median of 202.78 and 25.1% above the Drug Manufacturers industry median of 164.43. Sunshine Biopharma's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sunshine Biopharma (SBFM), the current Days Inventory is 205.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunshine Biopharma (SBFM) Overvalued in 2026?
Based on GuruFocus' analysis, Sunshine Biopharma stock appears to be undervalued.
The current stock price of $2.14 is trading 70.1% below its estimated GF Value™ of $7.15.
GuruFocus considers Sunshine Biopharma to be Possible Value Trap.
Key valuation signals for SBFM:
Days Inventory: 205.73 (near median its 10-year median of 202.78)
GF Value™: $7.15 vs. price of $2.14 (70.1% below fair value)
Industry Position: 25.1% above the Drug Manufacturers median (#592 of 918)
No single metric tells the full story. See the SBFM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
34GF Score
Get the complete analysis for SBFM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBFM has been successfully added to your 
